Development of a Dendritic Cell (DC) Vaccine for Advanced Colorectal Cancer

  • Richard S. Stubbs
  • Natalie Rains-Wilson
  • Rebecca J. Cannan
  • Wangxue Chen


Colorectal cancer is one of the most common malignancies encountered in the Western World and in-spite of the development of treatment strategies involving adjuvant chemotherapy, hepatic resection, hepatic cryotherapy and Selective Internal Radiation Therapy it continues to claim the lives of approximately 50% of those who develop the disease. While a great deal of effort has gone into the search for effective chemotherapeutic agents, to date no major advance in this area has been forthcoming. In parallel with this effort has been exploration for an effective immunotherapeutic strategy. There is good reason to believe this latter approach may deliver important advances in treatment over the next few years.


Colorectal Cancer Dendritic Cell Peripheral Blood Mononuclear Cell Advanced Colorectal Cancer Immature Dendritic Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pardoll, D.M., 1998, Cancer vaccines. Nat. Med. 4:525–531.PubMedCrossRefGoogle Scholar
  2. 2.
    Ockert, D., Schmitz, M., Hampl, M., Rieber, EP., 1999, Advances in cancer immunotherapy. lmmunol. Today 20:63–65.CrossRefGoogle Scholar
  3. 3.
    Nestle, F.O., Burg, G., Dummer, R., 1999, New perspectives on immunobiology and immunotherapy of melanoma. lmmunol. Today 20:5–7.CrossRefGoogle Scholar
  4. 4.
    Boon, T., Coulie, P.G., Van den Eynde, B., 1997, Tumor antigens recognized by T cells. lmmunol. Today 18:267–268.CrossRefGoogle Scholar
  5. 5.
    Ropponen, K.M., Eskelinen, M.J., Lipponen, P.K., et al., 1997 Prognostic value of tumour-infiltrating lymphocytes (T1Ls) in colorectal cancer. J. Pathol. 182:318–324.PubMedCrossRefGoogle Scholar
  6. 6.
    Ambe, K., Mori, M., Enjoji, M., 1989, S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer 63:496–503.PubMedCrossRefGoogle Scholar
  7. 7.
    Todryk, S.M., Chong, H., Vile, R.G., et al., 1998 Can immunotherapy by gene transfer tip the balance against colorectal cancer? Gut 43:445–449.PubMedCrossRefGoogle Scholar
  8. 8.
    . Avery, A., Paraskeva, C., Hall, P., et al., 1993, TGF-ß expression in the human colon: differential immunostaining along crypt epithelium. Br. J. Cancer 68:137–139.PubMedCrossRefGoogle Scholar
  9. 9.
    Tsushima, H., Kawata, S., Tamura, S., et al., 1996, High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology 10:375–382.CrossRefGoogle Scholar
  10. 10.
    Gastl, G.A., Abrams, J.S., Nanus, D.M., et al., 1993, Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55:96101.CrossRefGoogle Scholar
  11. 11.
    Gabrilovich, D.I., Chen, H.L., Girgis, K.R., et al., 1996, Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2:1096–1103.PubMedCrossRefGoogle Scholar
  12. 12.
    Troy, A., Davidson, P., Atkinson, C., Hart, D., 1998, Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer. J. Urol. 160:214–219.PubMedCrossRefGoogle Scholar
  13. 13.
    Chaux, P., Moutet, M., Faivre, J., et al., 1996, Inflammatory cells infiltrating human colorectal carcinoma express HLA class II but not B7–1 and B7–2 costimulatory molecules of the T-cell activation. Lab. Invest. 74:975–983.PubMedGoogle Scholar
  14. 14.
    Saito, T., Dworacki, G., Gooding, W., et al., 2000, Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. Clin. Can. Res. 6:1351–1364.Google Scholar
  15. 15.
    Steinman, R.M., Witmer, M.D., 1978, Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 75:5132–5136.PubMedCrossRefGoogle Scholar
  16. 16.
    Inaba, K., Granelli-Piperno, A., Steinman, R.M., 1983, Dendritic cells induce T Lymphocytes to release B cell-stimulating factors by an interleukin 2-dependent mechanism. J. Exp. Med. 158:2040–2057.PubMedCrossRefGoogle Scholar
  17. 17.
    Inaba, K., Steinman, R.M., Van Voorhis, W.C., Muramatsu, S., 1983, Dendritic cells are critical Accessory cells for thymus-dependent antibody responses in mouse and in man. Proc. Natl. Acad. Sci. USA 80:6041–6045.PubMedCrossRefGoogle Scholar
  18. 18.
    Feamley, D.B., Whyte, L.F., Camoutsos S.A, et al., 1999, Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 93:728–736.Google Scholar
  19. 19.
    Chen, W., Rains, N., Young, D., Stubbs, R.S., 2000, Dendritic cell-based cancer immunotherapy: Potential for treatment of colorectal cancer? Journal of Gastroenterology and Hepatology 15:698–705.PubMedCrossRefGoogle Scholar
  20. 20.
    Morse, M.A., Deng, Y., Coleman, D., et al., 1999, A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin. Cancer Res. 5:1331–1338.PubMedGoogle Scholar
  21. 21.
    Nair, S.K., Hull, S., Coleman, D., et al., 1999, Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. Int. J. Cancer 82:121–124.PubMedCrossRefGoogle Scholar
  22. 22.
    Nair, S.K., Boczkowski, D., Morse, M., et al., 1998, Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat. Biotechnol. 16:364–369.PubMedCrossRefGoogle Scholar
  23. 23.
    Gilboa, E., Nair, S.K., Lyerly, H.K., 1998, Immunotherapy of cancer with dendritic-cellbased vaccines. Cancer Immunol. Immunother. 46:82–87.PubMedCrossRefGoogle Scholar
  24. 24.
    Ashley, D.M., Faiola, B., Nair, S., et al., 1997, Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med. 186:1177–1182.PubMedCrossRefGoogle Scholar
  25. 25.
    Nair, S., Boczkowski, D., Snyder, D., Gilboa, E., 1997, Antigen presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines. Eur. J. Immunol. 27:589–597.PubMedCrossRefGoogle Scholar
  26. 26.
    Nair, S., Snyder, D., Rouse, B.T., Gilboa, E., 1997, Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int. J. Cancer 70:706–715.PubMedCrossRefGoogle Scholar
  27. 27.
    Fields, R.C., Shimizu, K., Mulo, J.J., 1998, Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. 95:9482–9487.CrossRefGoogle Scholar
  28. 28.
    Boczkowski, D., Nair, S.K., Snyder, D., Gilboa, E., 1996, Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:465–472.Google Scholar
  29. 29.
    Zitvogel, L., Mayordomo, J.I., Tjandrawan, T., et al., 1996, Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87–97.PubMedCrossRefGoogle Scholar
  30. 30.
    Hsu, F.J., Benike, C., Fagoni, F., et al., 1996, Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:52–58.PubMedCrossRefGoogle Scholar
  31. 31.
    Hsu, F.J., Caspar, C.B., Czerwinski, D., et al., 1997, Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - long term results of a clinical trial. Blood 89:3129–3135.PubMedGoogle Scholar
  32. 32.
    Nestle, F.O., Alijagic, S., Gilliet, M., et al., 1998, Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328–332.PubMedCrossRefGoogle Scholar
  33. 33.
    Murphy, G., Tjoa, B., Ragde, H., et al., 1996, Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate 29:371–380.PubMedCrossRefGoogle Scholar
  34. 34.
    Murphy, G.P., Tjoa, B.A., Simmons, S.J., et al., 1999, Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment. Prostate 39:54–59.PubMedCrossRefGoogle Scholar
  35. 35.
    Holtl, L., Rieser, C., Papesh, C., et al., 1999, Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J. Urol. 161:777–782.PubMedCrossRefGoogle Scholar
  36. 36.
    Rains, N., Cannan, R., Chen, W., Stubbs, R.S., 2000, Development of a dendritic cell (DC) based vaccine for patients with advanced colorectal cancer: Hepatogastroenterology (in press).Google Scholar
  37. 37.
    Young, J.W., Szabolcs, P., Moore, M.A.S., 1995, Identification of dendritic cell colony-forming units among normal CD4+ bone marrow progenitors that are expanded by c-kitligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J. Exp. Med. 182:1111–1119.PubMedCrossRefGoogle Scholar
  38. 38.
    Flores-Romo, L., Bjorck, P., Duvert, V., et al., 1997, CD40 ligation on human CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 185:341–349.PubMedCrossRefGoogle Scholar
  39. 39.
    Caux, C., Dezutter-Dambuyant, C., Schmitt, D., Banchereau, J., 1992, GM-CSF and TNFa cooperate in the generation of dendritic Langerhans cells. Nature 360:258–261.PubMedCrossRefGoogle Scholar
  40. 40.
    Caux, C., Massacrier, C., Vanbervliet, B., et al., 1994, Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263–1272.PubMedCrossRefGoogle Scholar
  41. 41.
    Maraskovsky, E., Brasel, K., Teepe, M., et al., 1996, Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 and ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953–1962.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Richard S. Stubbs
    • 1
  • Natalie Rains-Wilson
    • 1
  • Rebecca J. Cannan
    • 1
  • Wangxue Chen
    • 1
  1. 1.The Wakefield Gastroenterology Centre and Research InstituteWakefield HospitalWellingtonNew Zealand

Personalised recommendations